Degradation of histone deacetylase 4 via the TLR4/JAK/STAT1 signaling pathway promotes the acetylation of high mobility group box 1 (HMGB1) in lipopolysaccharide‐activated macrophages

High mobility group box 1 (HMGB1) has been proposed as crucial in the pathogenesis of many diseases including sepsis. Acetylation of HMGB1 prevents its entry into the nucleus and leads to its secretion from the cell where it can trigger inflammation. We hypothesized that histone deacetylase 4 (HDAC4) controls the acetylation of HMGB1 in lipopolysaccharide (LPS)‐stimulated RAW264.7 cells via the janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. The results showed that LPS treatment promoted the degradation of HDAC4 in a proteasome‐dependent manner, which led to HMGB1 acetylation. In LPS‐activated RAW264.7 cells, treatment with TAK‐242 (a toll like receptor 4 inhibitor) and pyridone 6 (a JAK inhibitor) significantly inhibited HDAC4 degradation and acetylation of HMGB1, and thus prevented secretion of HMGB1. Decreased phosphorylation of STAT1 was also observed. Interestingly, HDAC4 overexpression significantly prevented the acetylation and secretion of HMGB1 in both RAW264.7 cells and isolated murine peritoneal macrophages. We conclude that HDAC4 might be a useful target for the treatment of sepsis.

[1]  W. Teng,et al.  Glycyrrhizin, a Direct HMGB1 Antagonist, Ameliorates Inflammatory Infiltration in a Model of Autoimmune Thyroiditis via Inhibition of TLR2-HMGB1 Signaling. , 2017, Thyroid : official journal of the American Thyroid Association.

[2]  J. Cheon,et al.  Isoliquiritigenin inhibits TNF‐&agr;‐induced release of high‐mobility group box 1 through activation of HDAC in human intestinal epithelial HT‐29 cells , 2017, European journal of pharmacology.

[3]  Bin Wang,et al.  HMGB1 translocation and release mediate cigarette smoke–induced pulmonary inflammation in mice through a TLR4/MyD88-dependent signaling pathway , 2017, Molecular biology of the cell.

[4]  E. Park,et al.  Ethyl pyruvate inhibits the acetylation and release of HMGB1 via effects on SIRT1/STAT signaling in LPS-activated RAW264.7 cells and peritoneal macrophages. , 2016, International immunopharmacology.

[5]  K. Tracey,et al.  Regulation of Posttranslational Modifications of HMGB1 During Immune Responses. , 2016, Antioxidants & redox signaling.

[6]  M. Andrassy,et al.  Critical role of RAGE and HMGB1 in inflammatory heart disease , 2015, Proceedings of the National Academy of Sciences.

[7]  H. Seo,et al.  Deacetylation-mediated interaction of SIRT1-HMGB1 improves survival in a mouse model of endotoxemia , 2015, Scientific Reports.

[8]  F. Crews,et al.  Release of Neuronal HMGB1 by Ethanol through Decreased HDAC Activity Activates Brain Neuroimmune Signaling , 2014, PloS one.

[9]  Haichao Wang,et al.  Targeting HMGB1 in the treatment of sepsis , 2014, Expert opinion on therapeutic targets.

[10]  L. Moldawer,et al.  HMGB1 as a therapeutic target for sepsis: it's all in the timing! , 2014, Expert opinion on therapeutic targets.

[11]  K. Tracey,et al.  JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation , 2014, Proceedings of the National Academy of Sciences.

[12]  Ziying Wang,et al.  HDAC4/5-HMGB1 signalling mediated by NADPH oxidase activity contributes to cerebral ischaemia/reperfusion injury , 2013, Journal of cellular and molecular medicine.

[13]  Jae Heun Lee,et al.  Ethyl pyruvate induces heme oxygenase-1 through p38 mitogen-activated protein kinase activation by depletion of glutathione in RAW 264.7 cells and improves survival in septic animals. , 2012, Antioxidants & redox signaling.

[14]  Jae Heun Lee,et al.  Carbon Monoxide From CORM-2 Reduces HMGB1 Release Through Regulation of IFN-&bgr;/JAK2/STAT-1/INOS/NO Signaling But Not COX-2 in TLR-Activated Macrophages , 2010, Shock.

[15]  Jason P. Zlotnicki,et al.  High Mobility Group Box 1 Release from Hepatocytes during Ischemia and Reperfusion Injury Is Mediated by Decreased Histone Deacetylase Activity* , 2010, The Journal of Biological Chemistry.

[16]  D. Pisetsky,et al.  The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation , 2008, Modern rheumatology.

[17]  K. Tracey,et al.  HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2 , 2006, Shock.

[18]  Kevin J. Tracey,et al.  High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal , 2005, Nature Reviews Immunology.

[19]  U. Andersson,et al.  Mini‐review: The nuclear protein HMGB1 as a proinflammatory mediator , 2004, European journal of immunology.

[20]  Tiziana Bonaldi,et al.  Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion , 2003, The EMBO journal.

[21]  Haichao Wang,et al.  Targeting HMGB 1 in the treatment of sepsis , 2016 .